Skip to main content
Clinical Trials/ITMCTR2100004907
ITMCTR2100004907
Recruiting
Phase 4

An observation study on the long-term efficacy of Huisheng oral solution after radical operation of stage II to IIIb non-small cell lung cancer (NSCLC)

Sichuan Provincial People's Hospital0 sitesTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
on-small cell lung cancer(NSCLC)
Sponsor
Sichuan Provincial People's Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Sichuan Provincial People's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. The patient's aged \>\=18 years, and the gender is not limited;
  • 2\. Radical surgical treatment has been performed in the research center (Thoracic Surgery Department of Sichuan Provincial People's Hospital);
  • 3\. On the 5 ± 3 days after the operation, pathological examination was diagnosed as non\-small cell lung cancer, and according to the 8th edition of the International Society for the Study of Lung Cancer (IASLC) lung cancer TNM staging was stage II to IIIb;
  • 4\. The investigator assessed complete remission (CR) after the operation;
  • 5\. No history of allergies to the ingredients of Huisheng Oral Liquid in the past;
  • 6\. Performance Status: 0\-1 points;
  • 7\. The life expectancy is at least 12 weeks;
  • 8\. Laboratory examinations confirmed that the patient's blood routine and liver and kidney functions were normal within 7 days before the first medication;
  • 9\. The patient must have the ability to understand and voluntarily sign an informed consent form.

Exclusion Criteria

  • 1\. Merge other tumors;
  • 2\. Those with a history of deep vein thrombosis, pulmonary embolism, stroke, acute myocardial infarction, atrial fibrillation, patent foramen ovale, etc.;
  • 3\. Patients with bleeding tendency or coagulation disorders;
  • 4\.6 Those who have suffered acute spinal cord injury, have undergone joint replacement surgery, and have multiple traumas to hip, pelvic or lower limb fractures within 4\.6 months;
  • 5\. Suffer from uncontrollable neurological, mental illness or mental disorder, and poor compliance;
  • 6\. Patients who participate in other clinical trials at the same time;
  • 7\. Other situations that the researcher thinks are not suitable for inclusion in the group.

Outcomes

Primary Outcomes

Not specified

Similar Trials